Shorter treatment regimen found to be effective for treating TB

resisttb
Jun 24, 2021
1 min read

A research team led by a Medical University of South Carolina (MUSC) investigator reports in the May 6 issue of the New England Journal of Medicine that a four-month treatment regimen using rifapentine is effective for treating TB. Shortening the treatment duration is an important step toward increased patient adherence. Read here

Recent Posts

See All

TB Experts Rally Around New, Shortened TB Treatments

A regional training session for 20 countries has been successfully completed in Lima, Peru convened by PeerLNC, a global knowledge hub...

New Initiative Expands Access to Life Saving Drug-Resistant Tuberculosis Treatment

With the new $7.3 million Unitaid investment, Partners In Health (PIH) is beginning a new initiative to improve care and quality of life...

Open letter: Experts call for urgent expansion of Pretomanid label

Despite trials like TB-PRACTECAL displaying the efficacy of pretomanid in the expanded BPaLM regimen, the EMA only approved for the BPaL...

Commenti